MYLK and lung adenocarcinoma: Additionally, MLT has been shown to inhibit the migration of A549 human lung adenocarcinoma cells by reducing the expression level of osteopontin (OPN), myosin light-chain kinase (MLCK), and phosphorylation of MLC in A549 cells, while enhancing the expression of occludin [9].